1. Home
  2. WFCF vs KLRS Comparison

WFCF vs KLRS Comparison

Compare WFCF & KLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Where Food Comes From Inc.

WFCF

Where Food Comes From Inc.

HOLD

Current Price

$11.30

Market Cap

57.5M

Sector

Technology

ML Signal

HOLD

Logo Kalaris Therapeutics Inc.

KLRS

Kalaris Therapeutics Inc.

HOLD

Current Price

$8.30

Market Cap

46.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFCF
KLRS
Founded
1996
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.5M
46.0M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
WFCF
KLRS
Price
$11.30
$8.30
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$20.67
AVG Volume (30 Days)
1.9K
67.7K
Earning Date
02-19-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
45.82
N/A
EPS
0.53
N/A
Revenue
$25,512,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$21.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.26
$2.14
52 Week High
$13.78
$12.90

Technical Indicators

Market Signals
Indicator
WFCF
KLRS
Relative Strength Index (RSI) 46.05 42.21
Support Level $11.15 $8.75
Resistance Level $11.30 $9.48
Average True Range (ATR) 0.08 0.65
MACD 0.05 -0.18
Stochastic Oscillator 49.03 4.50

Price Performance

Historical Comparison
WFCF
KLRS

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.

About KLRS Kalaris Therapeutics Inc.

Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.

Share on Social Networks: